InspireMD Receives Nasdaq Notice for Minimum $1.00 Bid Price Noncompliance

What Happened
InspireMD, Inc. (NSPR) announced in an 8-K that on July 17, 2026 it received a notice from Nasdaq saying the company no longer meets the Nasdaq Capital Market minimum bid price requirement of $1.00 per share. Nasdaq based the determination on the closing bid price over 30 consecutive business days from June 3, 2026 through July 16, 2026. The notice does not affect immediate trading; NSPR will continue trading on Nasdaq while the company works to regain compliance.

Key Details

• Notice received: July 17, 2026; noncompliance based on closing prices from June 3–July 16, 2026 (30 consecutive business days).
• Compliance period: 180 calendar days; deadline to regain compliance is January 13, 2027.
• Regain requirement: closing bid of at least $1.00 per share for a minimum of 10 consecutive business days (Nasdaq may require a longer period).
• Possible next steps: if not compliant by Jan 13, 2027, the company may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq (the company may use a reverse stock split if necessary). If ineligible or unable to cure, Nasdaq could move to delist, with the company having appeal rights.

Why It Matters
A failure to meet Nasdaq’s minimum bid price rule is a listing risk that could lead to delisting if not cured, which can reduce liquidity and investor access to the stock. InspireMD’s disclosure gives shareholders a clear timeline (through Jan 13, 2027) and notes the company is evaluating options, including a reverse stock split, to restore compliance. Investors should monitor the company’s daily closing price and any further announcements about remedial actions or Nasdaq determinations.